Cargando…
The minimum clinically important difference: which direction to take
Over the past decades in modern medicine, there has been a shift from statistical significance to clinical relevance when it comes to interpreting results from clinical trials. A concept that is increasingly being used as a surrogate for clinical relevance and effect size calculation is the minimum...
Autores principales: | Draak, T. H. P., de Greef, B. T. A., Faber, C. G., Merkies, I. S. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593833/ https://www.ncbi.nlm.nih.gov/pubmed/30793428 http://dx.doi.org/10.1111/ene.13941 |
Ejemplares similares
-
Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial
por: Merkies, Ingemar S. J., et al.
Publicado: (2017) -
Deconstructing the Minimum Clinically Important Difference (MCID)
por: Molino, Janine, et al.
Publicado: (2022) -
Efficacy, safety, and tolerability of lacosamide in patients with gain-of-function Na(v)1.7 mutation-related small fiber neuropathy: study protocol of a randomized controlled trial–the LENSS study
por: de Greef, Bianca T. A., et al.
Publicado: (2016) -
Intravenous immunoglobulin therapy for small fiber neuropathy: study protocol for a randomized controlled trial
por: de Greef, Bianca T. A., et al.
Publicado: (2016) -
Neuropathic Pain due to Small Fiber Neuropathy in Aging: Current Management and Future Prospects
por: Brouwer, Brigitte A., et al.
Publicado: (2015)